News from other sources
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content
Pharmaceuticals
Gilead slips as sales of blockbuster hepatitis drugs fade | Bloomberg
Demand for the company's hepatitis drugs has been slipping. So the company is turning to new diseases for growth.
Safety, quality and clinical practice
A breakthrough stroke treatment can save lives—if it's available | The Wall Street Journal
Thrombectomies can prevent brain damage in stroke patients, but it's far from standard practice in the U.S.
FDA calls kratom an 'opioid' and warns against using the supplement | Stat
The agency said the herbal supplement is dangerous, comparing it to opioids, a finding it based on an analysis of the molecular structure of its ingredients.
Information technology
Florida judge tosses case alleging Epic's billing software caused fraudulent claims | Fierce Healthcare
In the suit, a compliance review specialist from WakeMed Health alleged that Epic's billing software double-billed Medicare and Medicaid for anesthesia services.
In other news
House passes bill to change Obamacare nutrition rules | The Weekly Standard
The Common Sense Nutrition Disclosure Act would weaken the requirement for chain restaurants to include calorie counts on thier menus.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 5 |